Modifiable factors influencing relapses and disability in multiple sclerosis

Multiple Sclerosis

Volumn 16, Issue 7, 2010, Pages 773-785

  D'Hooghe, M B ^a,b   Nagels, G ^a,c,d   Bissay, V ^e   De Keyser, J ^e,f  

^a National Multiple Sclerosis Center   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF MONS   (Belgium)

^d VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^e UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

disability progression; infections; multiple sclerosis; pregnancy; relapse; smoking; stress; vitamin D

Indexed keywords

ALCOHOL; ATORVASTATIN; BETA1A INTERFERON; DIPHTHERIA VACCINE; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GRANULOCYTE COLONY STIMULATING FACTOR; HEPATITIS B VACCINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; LENERCEPT; POLIOMYELITIS VACCINE; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VITAMIN D;

ALLERGIC ENCEPHALOMYELITIS; ANESTHESIA; BACTERIAL INFECTION; BREAST FEEDING; CLINICAL TRIAL; DIETARY INTAKE; DIPHTHERIA; DISABILITY; DISEASE COURSE; DISEASE EXACERBATION; EXERCISE; EXTERNAL BEAM RADIOTHERAPY; FITNESS; HEPATITIS B; HUMAN; INFLUENZA; INJURY; MENSTRUATION; MULTIPLE SCLEROSIS; NUTRITIONAL STATUS; ORAL CONTRACEPTION; PARASITOSIS; POLIOMYELITIS; PREGNANCY; PUERPERIUM; RELAPSE; REVIEW; RISK FACTOR; SMOKING HABIT; STRESS; SUN EXPOSURE; TETANUS; VACCINATION; VIRUS INFECTION; EVIDENCE BASED MEDICINE; FEMALE; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RISK ASSESSMENT; RISK REDUCTION; TIME;

DISABILITY EVALUATION; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PREGNANCY; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; TIME FACTORS;

EID: 77955017653     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510367721     Document Type: Review

References (90)

1. Tremlett H., Zhao Y., Joseph J., Devonshire V. Relapses in multiple sclerosis are age and time-dependent. J Neurol Neurosurg Psychiatry 2008 ; 79: 1368-1374.
2. French J., Gronseth G. Invited article: Lost in a jungle of evidence. Neurology 2008 ; 71: 1634-1638.
3. Scholten-Peeters GGM, Verhagen AP, Bekkering GE, et al. Prognostic factors of whiplash-associated disorders: a systematic review of prospective cohort studies. Pain 2003 ; 104: 303-322.
4. Sibley WA, Bamford CR, Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985 ; 1: 1313-1315.
5. Edwards S., Zvartau M., Clarke H., Irving W., Blumhardt LD Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998 ; 64: 736-741.
6. Rutschmann OT, McCrory DC, Matchar DB The Immunization Panel of the Multiple Sclerosis Council for Clinical Practice Guidelines. Immunization and MS. A summary of published evidence and recommendations. Neurology 2002 ; 59: 1837-1843.
7. Buljevac D., Flach HZ, Hop WCJ, et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 2002 ; 125: 952-960.
8. Rapp NS, Gilroy J., Lerner AM Role of bacterial infection in exacerbation of multiple sclerosis. Am J Phys Med Rehabil 1995 ; 74: 415-418.
9. Correale J., Fiol M., Gilmore W. The risk of relapses in multiple sclerosis during systemic infections. Neurology 2006 ; 67: 652-659.
10. Vollmer T. The natural history of relapses in multiple sclerosis. J Neurol Sc 2007 ; 256: S5-13.
11. Correale J., Farez M. Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 2007 ; 61: 97-108.
12. Confavreux C., Suissa S., Saddier P., Bourdös V., Vukusic S. Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med 2001 ; 344: 319-326. (Pubitemid 32107639)
13. Mikaeloff Y., Caricade G., Assi S., Tardieu M., Suissa S, on behalf of the KIDSEP study group of the French Neuropaediatric Society. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Brain 2007 ; 130: 1105-1110.
14. Centers for Disease Control. www.cdc.gov/ncidod/guidelines/guidelines- topic-vaccination.htm.
15. Zorgdrager A., De Keyser J. The premenstrual period and exacerbations in multiple sclerosis. Eur Neurol 2002 ; 48: 204-206.
16. Pozzilli C., Falaschi P., Mainero C., et al. MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns. Neurology 1999 ; 53: 622-624.
17. Holmqvist P., Wallberg M., Hammar M., Landtblom A-M., Brynhildsen J. Symptoms of multiple sclerosis in women in relation to sex steroid exposure. Maturitas 2006 ; 54: 149-153.
18. Poser S., Raun NE, Wikstróm, Poser W. Pregnancy, oral contraceptives and multiple sclerosis. Acta Neurol Scand 1979 ; 59: 108-118.
19. Hutchinson M. Pregnancy in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993 ; 56: 1043-1045.
20. Roullet E., Verdier-Taillefer M-H., Amarenco P., Gharbi G., Alperovitch A., Marteau R. Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients. J Neurol Neurosurg Psychiatry 1993 ; 56: 1062-1065.
21. Confavreux C., Hutchinson M., Hours MM, Cortinovis-Tourniaire P., Moreau T the Pregnancy in multiple sclerosis group. Rate of pregnancy-related relapse in multiple sclerosis. N Eng J Med 1998 ; 339: 285-291.
22. Vukusic S., Hutchinson M., Hours M., et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 2004 ; 127: 1353-1360.
23. Paavilainen T., Kurki T., Parkkola R., et al. Magnetic resonance imaging of the brain used to detect early postpartum activation in multiple sclerosis. Eur J Neurol 2007 ; 14: 1216-1221.
24. Weinshenker BG, Hader W., Carriere W., Baskerville J., Ebers GC The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario. Neurology 1989 ; 39: 1438-1440.
25. Thompson DS, Nelson LM, Burns A., Burks JS, Franklin GM The effects of pregnancy in multiple sclerosis: a retrospective study. Neurol 1986 ; 36: 1097-1099.
26. Koch M., Uyttenboogaart M., Heersema D., Steen C., De Keyser J. Parity and secondary progression. J Neurol Neurosurg Psychiatry 2009 ; 80: 676-678.
27. Runmarker B., Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995 ; 118: 253-261.
28. Verdru P., Theys P., Dghooghe MB, Carton H. Pregnancy and multiple sclerosis: the influence on long-term disability. Clin Neurol Neurosurg 1994 ; 96: 38-41.
29. Dghooghe MB, Nagels G., Uitdehaag BMJ. Long-term effects of childbirth in MS. J Neurol Neurosurg Psychiatry 2010 ; 81: 38-41.
30. Nelson LM, Franklin GM, Jones MC the multiple sclerosis study group. Risk of multiple sclerosis exacerbation during pregnancy and breastfeeding. JAMA 1988 ; 259: 3441-3443.
31. Achiron A., Kishner I., Dolev M., et al. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol 2004 ; 251: 1133-1137.
32. Langer-Gould A., Huang SM, Gupta R., et al. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol 2009 ; 66: 958-963.
33. Schwarz CE, Foley FW, Rao SM, Bernardin LJ, Lee H., Genderson MW Stress and course of disease in multiple sclerosis. Behav Med 1999 ; 25: 110-116.
34. Mohr DC, Hart SL, Julian L., Cox D., Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. Br Med J 2004 ; 328: 731-735.
35. Nisipeanu P., Korczyn AD Psychological stress as risk factor for exacerbations in multiple sclerosis. Neurology 1993 ; 43: 1311-1312.
36. Golan D., Somer E., Dishon S., Cuzin-Disegni L., Miller A. Impact of exposure to war stress on exacerbations of multiple sclerosis. Ann Neurol 2008 ; 64: 143-148.
37. Mohr DC, Goodkin DE, Bacchetti P., et al. Psychological stress and the subsequent appearance of new brain MRI lesions in MS. Neurology 2000 ; 55: 55-61.
38. Mohr DC, Goodkin DE, Nelson S., Cox D., Weiner M. Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis. Psychosom Med 2002 ; 64: 803-809.
39. Brown RF, Tennant CC, Sharrock M., Hodgkinson S., Dunn SM, Pollard JD Relationship between stress and relapse in multiple sclerosis: part I. Important features. Mult Scler 2006 ; 12: 453-464. (Pubitemid 44132586)
40. Mitsonis CI, Zervas IA, Mitropoulos PA, et al. The impact of stressful life events on risk of relapse in women with multiple sclerosis: A prospective study. Eur Psychiatry 2008 ; 23: 497-504.
41. Potagas C., Mitsonis C., Watier L., et al. Influence of anxiety and reported stressful life events on relapses in multiple sclerosis: a prospective study. Mult Scler 2009 ; 14: 1262-1268.
42. Buljevac D., Hop WCJ, Reedeker W., et al. Self-reported stressful life events and exacerbations in multiple sclerosis: prospective study. Br Med J 327: 327-646.
43. Sibley WA, Bamford CR, Clark K., Smith MS, Laguna JF A prospective study of physical trauma and multiple sclerosis. J Neurol Neurosurg Psychiatry 1991 ; 54: 584-589.
44. Goodin DS, Ebers GC, Johnson KP, Rodriguez M., Sibley WA, Wolinsky JS The relationship of MS to physical trauma and psychological stress: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1999 ; 52: 1737-1745.
45. Chaudhuri A., Behan PO Acute cervical hyperextension- hyperflexion injury may precipitate and/or exacerbate symptomatic MS. Eur J Neurol 2003 ; 10: 109-110.
46. Vercauteren M., Heytens L. Anaesthetic considerations for patients with a pre-existing neurological deficit: are neuraxial techniques safe? Acta Anaesthesiol Scand 2007 ; 51: 831-838.
47. Dorotta IR, Schubert A. Multiple sclerosis and anesthetic implications. Curr Opin Anaesthesiol 2002 ; 15: 365-370.
48. Bader AM, Hunt CO, Datta S., Naulty JS, Ostheimer GW Anesthesia for the obstetric patient with multiple sclerosis. J Clin Anesth 1988 ; 1: 21-24.
49. Miller RC, Lachance DH, Lucchinetti CF, et al. Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience. Int J Radiation Oncology Biol Phys 2006 ; 66: 1178-1186.
50. Peterson K., Rosenblum MK, Powers JM, Alvord E., Walker RW, Posner JB Effect of brain irradiation on demyelinating lesions. Neurology 1993 ; 43: 2105-2112.
51. Murphy CB, Hashimoto SA, Graeb D., Thiessen BA Clinical exacerbation of multiple sclerosis following radiotherapy. Arch Neurol 2003 ; 60: 273-275.
52. McMeekin RR, Hardman JM, Kempe LG Multiple sclerosis after X-radiation. Arch Otolaryng 1969 ; 90: 101-105.
53. Van Oosten BW, Barkhof F., Truyen L., et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 1996 ; 47: 1531-1534.
54. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 1999 ; 53: 457-465.
55. Openshaw H., Stuve O., Antel JP, et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology 2000 ; 54: 2147-2150.
56. Snir O., Lavie G., Achiron A., et al. G-CSF enhances the adhesion of encephalitogenic T cells to extracellular matrix components: a possible mechanism for exacerbation of multiple sclerosis. J Neuroimmunol 2006 ; 172: 145-155.
57. Birnbaum G., Cree B., Altafullah I., Zinser M., Reder AT Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. Neurology 2008 ; 71: 1309-1313.
58. Laplaud DA, Leray E., Barriöre P., Wiertlewski S., Moreau T. Increase in multiple sclerosis relapse rate following in vitro fertilization. Neurology 2006 ; 66: 1280-1281.
59. Hellwig K., Beste C., Brune N., et al. Increased MS relapse rate during assisted reproduction technique. J Neurol 2008 ; 255: 592-593.
60. Hellwig K., Schimrigk S., Beste C., Möller T., Gold R. Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. Eur Neurol 2009 ; 61: 65-68.
61. Freedman DM, Dosemeci M., Alavanja MCR. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med 2000 ; 57: 418-421.
62. Soilu-Hósignnninen M., Airas L., Mononen I., Heikkilósign A., Viljanen M., Hósignnninen A. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 2005 ; 11: 266-271.
63. Correale J., Ysrraelit MC, Gaitón MI Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 2009 ; 132: 1146-1160.
64. Soilu-Hósignnninen M., Laaksonen M., Laitinen I., Erósignlinna J-P., Lilius E. - M. Mononen I. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008 ; 79: 152-157.
65. Smolders J., Menheere P., Kessels A., Damoiseaux J., Hupperts R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 2008 ; 14: 1220-1224.
66. Tremlett H., van der Mei IAF, Pittas F., et al. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis. Neuroepidemiology 2008 ; 31: 271-279.
67. Van der Mei IAF, Ponsonby A-L., Dwyer T., Blizzard L., Taylor BV, Kilpatrick T. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 2007 ; 254: 581-590.
68. Woolmore JA, Stone M., Pye EM, et al. Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation. Mult Scler 2007 ; 13: 369-375.
69. Kragt JJ, van Amerongen BM, Killestein J., et al. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 2009 ; 15: 9-15.
70. Ramagopalan SV, Maugeri NJ, Handunnetthi L., et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009 ; 5: e1000369.
71. Di Pauli F., Reindl M., Ehling R., et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler 2008 ; 14: 1026-1030.
72. Hernan MA, Jick SS, Logroscino G., Olek MJ, Ascherio A., Jick H. Cigarette smoking and the progression of multiple sclerosis. Brain 2005 ; 128: 1461-1465.
73. Koch M., van Harten A., Uyttenboogaart M., De Keyser J. Cigarette smoking and progression in multiple sclerosis. Neurology 2007 ; 69: 1515-1520.
74. Sundstróm P., Nystróm L. Smoking worsens the prognosis in multiple sclerosis. Mult Scler 2008 ; 14: 1031-1035.
75. Pittas F., Ponsonby AL, Van der Mei IAF, et al. Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. J Neurol 2009 ; 256: 577-585.
76. Healy BC, Eman NA, Guttmann CRG, et al. Smoking and disease progression in multiple sclerosis. Arch Neurol 2009 ; 66: 858-864.
77. Zivadinov R., Weinstock-Guttman B., Hashmi K., et al. Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis. Neurology 2009 ; 73: 504-510.
78. Esparza ML, Sasaki S., Kesteloot H. Nutrition, latitude and multiple sclerosis mortality: an ecologic study. Am J Epidemiol 1995 ; 142: 733-737.
79. Farinotti M., Simi S., Di Pietrantonj C., et al. Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev 2007 ; 24: CD004192.
80. Swank RL, Goodwin J. Review of MS patient survival on a Swank low saturated fat diet. Nutrition 2003 ; 19: 161-162.
81. Schwarz S., Leweling H. Multiple sclerosis and nutrition. Mult Scler 2005 ; 11: 24-32.
82. Goodin DS the Northern California MS Study group. Survey of multiple sclerosis in Northern California. Mult Scler 1999 ; 5: 78-88.
83. Kelly DF, Kozlowski DA, Haddad E., Echiverri A., Hovda DA, Lee SM Ethanol reduces metabolic uncoupling following experimental head injury. J Neurotrauma 2000 ; 17: 261-272.
84. Prakash RS, Snook EM, Erickson KI, et al. Cardiorespiratory fitness: a predictor of cortical plasticity in multiple sclerosis. Neuroimage 2007 ; 34: 1238-1244.
85. Stuifbergen AK, Blozis SA, Harrison TC, Becker HA Exercise, functional limitations, and quality of life: a longitudinal study of persons with multiple sclerosis. Arch Phys Med Rehabil 2006 ; 87: 935-943.
86. Kramer AF, Erickson KI, Colcombe SJ Exercise, cognition and the aging brain. J Appl Physiol 2006 ; 101: 1237-1242.
87. Deary IJ, Whalley LJ, Batty GD, Starr JM Physical fitness and lifetime cognitive change. Neurology 2006 ; 67: 1195-1200.
88. Kópke S., Kasper J., Möhlhauser I., Nöbling M., Heesen C. Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial. Multiple Sclerosis 2009 ; 15: 96-104.
89. Lym YL, Joh HK Serum 25-hydroxyvitamin D3 is related to fish intake and exercise in Korean adult men. Asia Pac J Clin Nutr 2009 ; 18: 372-376.
90. Knight JA, Wong J., Blackmore C., Raboud JM, Vieth R. Vitamin association with progesterone and estradiol in young women. Cancer Causes Control 2010 ; 21: 479-483.